Cancer Prevention News and Research

RSS

New Epigenetic Vulnerability Of Acute Myeloid Leukemia Revealed

Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Because of the poor outcomes of this disease, researchers across the globe have been on the hunt for new ways to treat AML, while preserving normal blood development.

10 Apr 2023

UTA professor leads a state-funded project to explore how T-cells detect cancer

A University of Texas at Arlington bioengineering professor is leading a state-funded project that will try to identify what T-cells are detecting in cancerous cells to better craft a personalized cancer immunotherapy.

23 Feb 2023

Research provides insight into the regulation of heartbeats

UT Southwestern Medical Center researchers have mapped gene control elements in specialized cardiac cells responsible for coordinating heartbeats. The findings of the genome exploration study, published in The Journal of Clinical Investigation, provide insight into how heartbeats are regulated and could impact diagnosis and risk prediction for a variety of common arrhythmias.

14 Feb 2023

Researchers pioneer a new approach to study mosquito's DNA

When it comes to DNA, one pesky mosquito turns out to be a rebel among species.

10 Feb 2023

Telomeres, mitochondria, and inflammation: Working in synergy to fight cancer

The telomeres, or ends of the chromosomes, increasingly shorten as people age. Recently, Salk researchers found that when telomeres are very short, they can still interact with the mitochondria, the cell’s powerhouses.

9 Feb 2023

Groundbreaking discovery could lead to new ways of controlling gene regulation

UT Southwestern Medical Center researchers have discovered a method cells use to turn genes on and off that involves portions of proteins whose function has long been a mystery.

6 Feb 2023

NIH funds research on mRNA vaccines to stop cancer development

The National Cancer Institute at the National Institutes of Health has awarded a multidisciplinary team of Weill Cornell Medicine researchers a five-year $5.7 million grant to support a center dedicated to creating messenger RNA (mRNA) vaccines to prevent the development of cancer in at-risk groups.

15 Nov 2022

AI tools forecast DNA’s regulatory region and 3D structure

According to two recent research published in Nature Genetics, recently created artificial intelligence (AI) tools effectively identified the function of DNA’s regulatory regions and three-dimensional (3D) structure based only on its raw sequence.

9 Aug 2022

Researchers capture images of antibodies attacking neuron receptors using Cryo-Electron Microscopy Facility

Scientists have for the first time photographed an autoantibody coupled to a receptor on the surface of a nerve cell using the Cryo-Electron Microscopy Facility at UT Southwestern.

14 Jul 2022

Research may lead to new therapies for metabolic disorders and other diseases

Researchers at UT Southwestern have uncovered a molecular path that allows cells to detect when their lipid supplies are running low, triggering a flurry of activity that avoids starvation.

23 May 2022

Vitamin E can reinvigorate dendritic cells to enhance immunotherapy responses

Combining a retrospective analysis of clinical records with in-depth laboratory studies, researchers at The University of Texas MD Anderson Cancer Center have discovered that vitamin E can enhance immunotherapy responses by stimulating the activity of dendritic cells in the tumor.

18 Apr 2022

Breakthrough discovery provides a desirable drug target to tackle metabolic diseases

In a breakthrough discovery, scientists from The University of Texas Health Science Center at San Antonio today reported that inhibiting a liver enzyme in obese mice decreased the rodents' appetite, increased energy expenditure in adipose (fat) tissues and resulted in weight loss.

6 Apr 2022

Researchers discover new fluorescent DNA label, likely to help detect cancer risk

Scientists develop a new fluorescent label that provides a sharper image of how DNA architecture is disturbed in cancer cells.

From University of Pittsburgh 7 Mar 2022

Two distinct classes of stem cells drive treatment resistance in patients with myelodysplastic syndromes

Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells.

3 Mar 2022

Cancer Prevention News and Research

New Epigenetic Vulnerability Of Acute Myeloid Leukemia Revealed

UTA professor leads a state-funded project to explore how T-cells detect cancer

Research provides insight into the regulation of heartbeats

Researchers pioneer a new approach to study mosquito's DNA

Telomeres, mitochondria, and inflammation: Working in synergy to fight cancer

Groundbreaking discovery could lead to new ways of controlling gene regulation

NIH funds research on mRNA vaccines to stop cancer development

AI tools forecast DNA’s regulatory region and 3D structure

Researchers capture images of antibodies attacking neuron receptors using Cryo-Electron Microscopy Facility

Research may lead to new therapies for metabolic disorders and other diseases

Vitamin E can reinvigorate dendritic cells to enhance immunotherapy responses

Breakthrough discovery provides a desirable drug target to tackle metabolic diseases

Researchers discover new fluorescent DNA label, likely to help detect cancer risk

Two distinct classes of stem cells drive treatment resistance in patients with myelodysplastic syndromes

UH researcher secures $2 million to develop drugs for formerly undruggable cancer targets

Human nose organoids reveal the first events of SARS-CoV-2 and RSV infection

Researchers develop a method for preserving human primordial germ cell-like cells

San Antonio researchers report a new mechanistic target for leukemia drug development

Peptide-enhanced, biological cancer drug may help treat breast cancer metastasis to bone

Targeting MAPK4 in triple-negative breast cancer may lead to improved treatments

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics